405 related articles for article (PubMed ID: 27170000)
21. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
[TBL] [Abstract][Full Text] [Related]
24. Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study.
Ghazal F; Theobald H; Rosenqvist M; Al-Khalili F
PLoS One; 2018; 13(5):e0198069. PubMed ID: 29795689
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
[TBL] [Abstract][Full Text] [Related]
26. Factors that influence awareness and treatment of atrial fibrillation in older adults.
Frewen J; Finucane C; Cronin H; Rice C; Kearney PM; Harbison J; Kenny RA
QJM; 2013 May; 106(5):415-24. PubMed ID: 23504411
[TBL] [Abstract][Full Text] [Related]
27. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
28. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.
Lowres N; Olivier J; Chao TF; Chen SA; Chen Y; Diederichsen A; Fitzmaurice DA; Gomez-Doblas JJ; Harbison J; Healey JS; Hobbs FDR; Kaasenbrood F; Keen W; Lee VW; Lindholt JS; Lip GYH; Mairesse GH; Mant J; Martin JW; Martín-Rioboó E; McManus DD; Muñiz J; Münzel T; Nakamya J; Neubeck L; Orchard JJ; Pérula de Torres LÁ; Proietti M; Quinn FR; Roalfe AK; Sandhu RK; Schnabel RB; Smyth B; Soni A; Tieleman R; Wang J; Wild PS; Yan BP; Freedman B
PLoS Med; 2019 Sep; 16(9):e1002903. PubMed ID: 31553733
[TBL] [Abstract][Full Text] [Related]
29. Treatment with oral anticoagulant drugs restrained from patients with atrial fibrillation: An assessment in a geographically well-defined catchment area.
Andersson P; Löndahl M
Eur J Prev Cardiol; 2016 Sep; 23(13):1437-43. PubMed ID: 26976847
[TBL] [Abstract][Full Text] [Related]
30. Opportunistic atrial fibrillation screening in primary care in Ireland: results of a pilot screening programme.
Callanan A; Quinlan D; Kearney PM; O'Sullivan S; Zhi GTY; Crichton A; Howell MW; Bradley C; Buckley C
Open Heart; 2024 May; 11(1):. PubMed ID: 38724265
[TBL] [Abstract][Full Text] [Related]
31. Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry.
Kaya H; Ertaş F; Köroğlu B; Vatan B; Çağlıyan ÇE; Gedik S; Yeter E; Aydin M; Akil MA; Soydinç MS; Ozhan H; Ülgen MS;
Clin Appl Thromb Hemost; 2015 Mar; 21(2):144-8. PubMed ID: 23742948
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation case finding in over 65 s with cardiovascular risk factors - Results of initial Scottish clinical experience.
Grubb NR; Elder D; Broadhurst P; Reoch A; Tassie E; Neilson A
Int J Cardiol; 2019 Aug; 288():94-99. PubMed ID: 31047704
[TBL] [Abstract][Full Text] [Related]
33. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.
Guo Y; Tian Y; Wang H; Si Q; Wang Y; Lip GYH
Chest; 2015 Jan; 147(1):109-119. PubMed ID: 24921459
[TBL] [Abstract][Full Text] [Related]
34. Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey.
Potpara TS; Dan GA; Trendafilova E; Goda A; Kusljugic Z; Manola S; Music L; Musetescu R; Badila E; Mitic G; Paparisto V; Dimitrova ES; Polovina MM; Petranov SL; Djergo H; Loncar D; Bijedic A; Brusich S; Lip GY;
Sci Rep; 2016 Feb; 6():20432. PubMed ID: 26869284
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool.
Shantsila E; Wolff A; Lip GY; Lane DA
Int J Clin Pract; 2015 Aug; 69(8):840-5. PubMed ID: 25752615
[TBL] [Abstract][Full Text] [Related]
36. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
[TBL] [Abstract][Full Text] [Related]
37. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
Lip GY; Skjøth F; Rasmussen LH; Larsen TB
J Am Coll Cardiol; 2015 Apr; 65(14):1385-94. PubMed ID: 25770314
[TBL] [Abstract][Full Text] [Related]
38. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
39. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
Wolff A; Shantsila E; Lip GY; Lane DA
Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
[TBL] [Abstract][Full Text] [Related]
40. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
